223 related articles for article (PubMed ID: 3321412)
21. Comparative in vitro activity of norfloxacin against urinary tract pathogens.
Haase D; Urias B; Harding G; Ronald A
Eur J Clin Microbiol; 1983 Jun; 2(3):235-41. PubMed ID: 6224679
[TBL] [Abstract][Full Text] [Related]
22. Norfloxacin versus co-trimoxazole in the treatment of acute bacterial diarrhoea: a placebo controlled study.
Lolekha S; Patanachareon S; Thanangkul B; Vibulbandhitkit S
Scand J Infect Dis Suppl; 1988; 56():35-45. PubMed ID: 3074464
[TBL] [Abstract][Full Text] [Related]
23. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.
Arredondo-García JL; Figueroa-Damián R; Rosas A; Jáuregui A; Corral M; Costa A; Merlos RM; Ríos-Fabra A; Amábile-Cuevas CF; Hernández-Oliva GM; Olguín J; Cardeñosa-Guerra O;
J Antimicrob Chemother; 2004 Oct; 54(4):840-3. PubMed ID: 15347634
[TBL] [Abstract][Full Text] [Related]
24. A multicenter, double-blind, trimethoprim-sulfamethoxazole controlled study of enoxacin in the treatment of patients with complicated urinary tract infections.
Cox CE; Drylie DM; Klimberg I; Childs SJ; Wegenke JD; Malek GH; Harrison LH; McCullough DL; Finegold SM; George WL
J Urol; 1989 Mar; 141(3):575-8. PubMed ID: 2645421
[TBL] [Abstract][Full Text] [Related]
25. Comparison of cefixime and co-trimoxazole in acute uncomplicated urinary tract infection. A double-blind general practice study.
Levenstein J; Summerfield PJ; Fourie S; Brink G; Michaelides B; Murray E; Naidoo N
S Afr Med J; 1986 Oct; 70(8):455-60. PubMed ID: 3535127
[TBL] [Abstract][Full Text] [Related]
26. Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid. A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections.
Vogel R; Deaney NB; Round EM; VandenBurg MJ; Currie WJ
J Antimicrob Chemother; 1984 May; 13 Suppl B():113-20. PubMed ID: 6234271
[TBL] [Abstract][Full Text] [Related]
27. Norfloxacin: in vitro activity compared with that of seven other antibacterial agents against urinary tract pathogens.
Digranes A; Dibb WL; Ostervold B
Acta Pathol Microbiol Immunol Scand B; 1984 Apr; 92(2):101-6. PubMed ID: 6233841
[TBL] [Abstract][Full Text] [Related]
28. Sultamicillin versus trimethoprim/sulfamethoxazole in the treatment of urinary tract infections.
Naber KG; Wittenberger R
APMIS Suppl; 1989; 5():57-62. PubMed ID: 2660873
[TBL] [Abstract][Full Text] [Related]
29. Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis.
Bow EJ; Rayner E; Louie TJ
Am J Med; 1988 May; 84(5):847-54. PubMed ID: 3284340
[TBL] [Abstract][Full Text] [Related]
30. Trimethoprim in vitro antibacterial activity is not increased by adding sulfamethoxazole for pediatric Escherichia coli urinary tract infection.
Nguyen HT; Hurwitz RS; Defoor WR; Minevich E; McAdam AJ; Mortensen JE; Novak-Weekley SM; Minnillo BJ; Elder JS
J Urol; 2010 Jul; 184(1):305-10. PubMed ID: 20488468
[TBL] [Abstract][Full Text] [Related]
31. The antimicrobial spectrum of norfloxacin.
Newsom SW
J Antimicrob Chemother; 1984 May; 13 Suppl B():25-31. PubMed ID: 6234272
[TBL] [Abstract][Full Text] [Related]
32. A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections.
Stein GE; Mummaw N; Goldstein EJ; Boyko EJ; Reller LB; Kurtz TO; Miller K; Cox CE
Arch Intern Med; 1987 Oct; 147(10):1760-2. PubMed ID: 3310941
[TBL] [Abstract][Full Text] [Related]
33. Comparison of cinoxacin and co-trimoxazole in the treatment of urinary tract infections.
de Jersey P; Wooller HO
Med J Aust; 1982 Mar; 1(6):267-8. PubMed ID: 7045606
[TBL] [Abstract][Full Text] [Related]
34. In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.
Shungu DL; Weinberg E; Gadebusch HH
Antimicrob Agents Chemother; 1983 Jan; 23(1):86-90. PubMed ID: 6219622
[TBL] [Abstract][Full Text] [Related]
35. A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
Shrire L; Saunders J; Traynor R; Koornhof HJ
Eur J Clin Microbiol; 1984 Aug; 3(4):328-32. PubMed ID: 6237900
[TBL] [Abstract][Full Text] [Related]
36. Comparison of once daily trimethoprim and standard co-trimoxazole in urinary infections. A clinical trial in general practice.
Cartwright KA; Stanbridge TN; Cooper J
Practitioner; 1982 Jan; 226(1363):152-6. PubMed ID: 7043438
[No Abstract] [Full Text] [Related]
37. Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults.
Gotuzzo E; Oberhelman RA; Maguiña C; Berry SJ; Yi A; Guzman M; Ruiz R; Leon-Barua R; Sack RB
Antimicrob Agents Chemother; 1989 Jul; 33(7):1101-4. PubMed ID: 2675757
[TBL] [Abstract][Full Text] [Related]
38. A comparison of Mictral with co-trimoxazole in the treatment of urinary tract infections.
Healey JC
Practitioner; 1982 Nov; 226(1373):1971-4. PubMed ID: 6760166
[No Abstract] [Full Text] [Related]
39. Treatment of urinary tract infection with a single dose of amoxycillin, co-trimoxazole, or trimethoprim.
Harbord RB; Grüneberg RN
Br Med J (Clin Res Ed); 1981 Nov; 283(6302):1301-2. PubMed ID: 6794831
[No Abstract] [Full Text] [Related]
40. Effectiveness and tolerability of short course co-trimoxazole, norfloxacin and levofloxacin in bacteriological cure of uncomplicated urinary tract infection in outpatient setting. An open label, parallel group, randomized controlled trial.
Vachhani AV; Barvaliya M; Naik V; Jha P; Tripathi C
Infez Med; 2015 Jun; 23(2):155-60. PubMed ID: 26110296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
